Inventor
HU WENQI
US18 patents
⚠️ This page may combine multiple inventors who share the name “HU WENQI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BEIJING MABWORKS BIOTECH CO LTD
14 patentsUS10570210B1Feb 25, 2020
Antibodies binding CD40 and uses thereof
BEIJING MABWORKS BIOTECH CO LTD13 citations93
US10421817B1Sep 24, 2019
Antibodies binding human Claudin 18.2 and uses thereof
BEIJING MABWORKS BIOTECH CO LTD33 citations93
US10442866B1Oct 15, 2019
Antibodies binding OX40 and uses thereof
BEIJING MABWORKS BIOTECH CO LTD8 citations81
US10946092B1Mar 16, 2021
Antibodies binding LAG3 and methods of treatment using them
BEIJING MABWORKS BIOTECH CO LTD3 citations72
US10662249B1May 26, 2020
Antibodies targeting CD40 and uses thereof
BEIJING MABWORKS BIOTECH CO LTD1 citations72
US10577424B1Mar 3, 2020
Antibodies binding VISTA and uses thereof
BEIJING MABWORKS BIOTECH CO LTD5 citations72
US11718674B2Aug 8, 2023
Antibodies binding PD-L1 and uses thereof
BEIJING MABWORKS BIOTECH CO LTD0 citations62
US11091558B2Aug 17, 2021
Anti-OX40 antibodies and uses thereof
BEIJING MABWORKS BIOTECH CO LTD0 citations60
US12084520B2Sep 10, 2024
Antibodies binding BCMA and CD3 and uses thereof
BEIJING MABWORKS BIOTECH CO LTD0 citations57
US12590155B2Mar 31, 2026
Molecules binding PD-L1 and uses thereof
BEIJING MABWORKS BIOTECH CO LTD0 citations54
US10654939B1May 19, 2020
Antibodies specific to CD40 and uses thereof
BEIJING MABWORKS BIOTECH CO LTD0 citations51
US10654938B1May 19, 2020
CD40 binding antibodies and uses thereof
BEIJING MABWORKS BIOTECH CO LTD0 citations51
US10654937B1May 19, 2020
CD40 specific antibodies and uses thereof
BEIJING MABWORKS BIOTECH CO LTD0 citations51
US10647776B1May 12, 2020
Anti-CD40 antibodies and uses thereof
BEIJING MABWORKS BIOTECH CO LTD0 citations51